Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in WHWK — Whitehawk Therapeutics, Inc.

CIK 916542 Boston, MA
Back to WHWK Full portfolio

Position in WHWK

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$782,644
+$540,796 QoQ
Shares Held
170,883
+143.8% QoQ
Ownership
0.300%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 78 holders
Holding Since
Sep 2020
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in WHWK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. WHWK ranks #76 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 1,664,999 $188,744,286
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,440 $98,170,137
3 IMCR
Immunocore Holdings plc
 1,209,894 $38,414,134
4 RIGL
Rigel Pharmaceuticals Inc
 591,686 $23,146,756
5 EXEL
Exelixis, Inc.
 421,444 $22,930,768
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,122 $20,923,261
7 TBPH
Theravance Biopharma, Inc.
 1,174,910 $19,973,470
8 PRTA
Prothena Corp Public Ltd Co
 2,010,645 $19,684,214

All Filings in WHWK

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $782,644 170,883
2026-03-31 $241,848 70,101
2025-12-31 $59,614 24,634
2025-09-30 $49,791 26,206
2021-09-30 $597,473 20,343